Explore
Validate
LearnAMAb90510
antibody from Atlas Antibodies
Targeting: ZEB1
AREB6, BZP, FECD6, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a
Western blot
Immunocytochemistry
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AMAb90510 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#AMAb90510, RRID:AB_2665569
- Product name
- Anti-ZEB1
- Antibody type
- Monoclonal
- Description
- Monoclonal Antibody against Human ZEB1, Clone ID: CL0151, Gene description: zinc finger E-box binding homeobox 1, Alternative Gene Names: AREB6, BZP, NIL-2-A, PPCD3, TCF8, ZEB, Zfhep, Zfhx1a, Validated applications: ICC, IHC, WB, Uniprot ID: P37275, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- CL0151
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references p53 Affects Zeb1 Interactome of Breast Cancer Stem Cells
TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties.
The immunophenotype of epithelial to mesenchymal transition inducing transcription factors in salivary gland adenoid cystic carcinomas
Proteomic Analysis of Zeb1 Interactome in Breast Carcinoma Cells
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease.
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.
Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.
Parfenyev S, Shabelnikov S, Tolkunova E, Barlev N, Mittenberg A
International Journal of Molecular Sciences 2023;24(12):9806
International Journal of Molecular Sciences 2023;24(12):9806
TGFß1 Stimulates Lymphatic Endothelial Cells to Produce IL7 and IL15, Which Act as Chemotactic Factors for Breast Cancer Cells with Mesenchymal Properties.
Giotopoulou N, Shi W, Parniewska MM, Sun W, Fuxe J
Journal of mammary gland biology and neoplasia 2023 Dec 6;28(1):25
Journal of mammary gland biology and neoplasia 2023 Dec 6;28(1):25
The immunophenotype of epithelial to mesenchymal transition inducing transcription factors in salivary gland adenoid cystic carcinomas
Belulescu I, Mărgăritescu C, Dumitrescu C, Munteanu M, Dăguci L, Mărgăritescu O, Matei M
Romanian Journal of Morphology and Embryology 2021;61(3):769-782
Romanian Journal of Morphology and Embryology 2021;61(3):769-782
Proteomic Analysis of Zeb1 Interactome in Breast Carcinoma Cells
Parfenyev S, Shabelnikov S, Pozdnyakov D, Gnedina O, Adonin L, Barlev N, Mittenberg A
Molecules 2021;26(11):3143
Molecules 2021;26(11):3143
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease.
Kinchen J, Chen HH, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner-Corbett D, Ashley N, Cubitt L, Mellado-Gomez E, Attar M, Sharma E, Wills Q, Bowden R, Richter FC, Ahern D, Puri KD, Henault J, Gervais F, Koohy H, Simmons A
Cell 2018 Oct 4;175(2):372-386.e17
Cell 2018 Oct 4;175(2):372-386.e17
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression.
Roy A, Attarha S, Weishaupt H, Edqvist PH, Swartling FJ, Bergqvist M, Siebzehnrubl FA, Smits A, Pontén F, Tchougounova E
Oncotarget 2017 Apr 11;8(15):24815-24827
Oncotarget 2017 Apr 11;8(15):24815-24827
Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S, Raulefs S, Bruns P, Afonso-Grunz F, Plötner A, Thermann R, Jäger C, Schlitter AM, Kong B, Regel I, Roth WK, Rotter B, Hoffmeier K, Kahl G, Koch I, Theis FJ, Kleeff J, Winter P, Michalski CW
Molecular cancer 2015 Apr 25;14:94
Molecular cancer 2015 Apr 25;14:94
Grainyhead-like 2 (GRHL2) distribution reveals novel pathophysiological differences between human idiopathic pulmonary fibrosis and mouse models of pulmonary fibrosis.
Varma S, Mahavadi P, Sasikumar S, Cushing L, Hyland T, Rosser AE, Riccardi D, Lu J, Kalin TV, Kalinichenko VV, Guenther A, Ramirez MI, Pardo A, Selman M, Warburton D
American journal of physiology. Lung cellular and molecular physiology 2014 Mar 1;306(5):L405-19
American journal of physiology. Lung cellular and molecular physiology 2014 Mar 1;306(5):L405-19
No comments: Submit comment
Enhanced validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Genetic validation
- Main image
- Experimental details
- Western blot analysis in Rh30 cells transfected with control siRNA, target specific siRNA probe #1 and #2, using Anti-ZEB1 antibody. Remaining relative intensity is presented. Loading control: Anti-GAPDH.
- Sample type
- Human
- Protocol
- Protocol
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human endometrium and liver tissues using AMAb90510 antibody. Corresponding ZEB1 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
